Cyonna Holmes earned her PhD in Biomedical Engineering from the University of Texas Southwestern Medical Center (Dallas, TX, US) and her BS in Bioengineering from Stanford University (Stanford, CA, US). At Celanese, Dr Holmes serves as Global Strategy Lead for Ophthalmology, Rare Diseases and RNA Therapeutics. She has experience in the areas of drug delivery, lifecycle management strategy, new product development and market entry strategy. She has published articles in peer-reviewed journals.

More contributions